Table 1.
Patient groups, growth factor, and protein levels
| Sample type | TGF-β2 (ng/ml) | B-FGF (pg/ml) | Il-6 (pg/ml) | Protein (mg/ml) |
| Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | |
| Retro-oil fluid (n = 13) | 1.65 (1.03–2.30) | 50.85 (28.46–60.48) | 572.18 (523.81–581.37) | 736.32 (343.63–1368.56) |
| Macular hole vitreous (n = 10) | 1.07 (0.65–1.90) | 0.18 (0.15–1.76) | 0.98 (0.9–1.43) | 20.60 (8.95–49.83) |
| Revision-vitrectomy fluid (n = 11) | 1.24 (0.93–1.78) | 2.14 (1.05–2.48) | 515.18 (78.38–615.08) | 149.22 (46.77–593.8) |
| No preoperative PVR vitreous (n = 244) | 1.54 (0.70–3.13) | 1.99 (0.72–10.77) | 106.88 (31.28–384.23) | 75.5 (30–151) |
| Preoperative PVR vitreous (n = 31) | 1.70 (1.03–2.85) | 13.21 (5.11–59.19) | 296.93 (63.0–628.58) | 218 (112–706.92) |
| Non retro-oil samples combined | 1.51 (0.79–3.1) | 2.23 (0.77–12.63) | 110.1 (29.18–418.65) | 81.5 (30.415–173.98) |
IQR, interquartile range.